Neurons from AD patients display elevated p16 levels compared to healthy controls, with increased CDKN2A mRNA expression in the prefrontal cortex, but not in white matter regions enriched in glial cells (Herdy et al. 2022). Here, CDKN2A is linked to Alzheimer disease.